Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas J Veale

Showing results (1-10 of 170) with videos related to

Pageof 17
Sort By:
Frontiers in Medicine|May 7, 2019
Synovial Tissue Biopsy ResearchDouglas J Veale
Clinical and Experimental Rheumatology|June 26, 2010
What can we learn from negative clinical trials in systemic sclerosis?Douglas J Veale
Ebiomedicine|July 3, 2015
Key Challenges in Rheumatic and Musculoskeletal Disease Translational ResearchUrsula Fearon, Douglas J Veale
Methods in Molecular Medicine|October 24, 2007
Angiogenesis in arthritis: methodological and analytical detailsUrsula Fearon, Douglas J Veale
Best Practice & Research. Clinical Rheumatology|September 19, 2006
Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targetingDouglas J Veale, Ursula Fearon
Nature Reviews. Rheumatology|December 26, 2019
Next-generation analysis of synovial tissue architectureDouglas J Veale, Ursula Fearon
Lancet (London, England)|June 13, 2018
The pathogenesis of psoriatic arthritisDouglas J Veale, Ursula Fearon
The Journal of Rheumatology|May 5, 2010
Irish smokers with rheumatoid arthritis suffer more than their nonsmoking counterpartsLeonard C Harty, Douglas J Veale
Drugs|October 25, 2002
Management of spondyloarthropathy: new pharmacological treatment optionsRuth Z Lee, Douglas J Veale
The Journal of Rheumatology. Supplement|August 8, 2009
Psoriatic arthritis management update - biotherapeutic optionsTajvur P Saber, Douglas J Veale
Pageof 17

Showing results (1-10 of 170) with videos related to

Sort By:
Pageof 17
Frontiers in Medicine|May 7, 2019
Synovial Tissue Biopsy ResearchDouglas J Veale
Clinical and Experimental Rheumatology|June 26, 2010
What can we learn from negative clinical trials in systemic sclerosis?Douglas J Veale
Ebiomedicine|July 3, 2015
Key Challenges in Rheumatic and Musculoskeletal Disease Translational ResearchUrsula Fearon, Douglas J Veale
Methods in Molecular Medicine|October 24, 2007
Angiogenesis in arthritis: methodological and analytical detailsUrsula Fearon, Douglas J Veale
Best Practice & Research. Clinical Rheumatology|September 19, 2006
Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targetingDouglas J Veale, Ursula Fearon
Nature Reviews. Rheumatology|December 26, 2019
Next-generation analysis of synovial tissue architectureDouglas J Veale, Ursula Fearon
Lancet (London, England)|June 13, 2018
The pathogenesis of psoriatic arthritisDouglas J Veale, Ursula Fearon
The Journal of Rheumatology|May 5, 2010
Irish smokers with rheumatoid arthritis suffer more than their nonsmoking counterpartsLeonard C Harty, Douglas J Veale
Drugs|October 25, 2002
Management of spondyloarthropathy: new pharmacological treatment optionsRuth Z Lee, Douglas J Veale
The Journal of Rheumatology. Supplement|August 8, 2009
Psoriatic arthritis management update - biotherapeutic optionsTajvur P Saber, Douglas J Veale
Pageof 17